ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Moderna regains RSV vaccine programme from Merck pharmaceutical-technology
October 12, 2020Merck (MSD) has returned all rights to a respiratory syncytial virus (RSV) vaccine, mRNA-1172, to Moderna, including rights to develop vaccines against the virus for adults.
Pharma Sources Insight January 2025
